Article info
PDFCardiovascular medicine
Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease
- Correspondence to:
Dr T Reffelmann, Medizinische Klinik I, University Hospital, Rheinisch-Westfälische Technische Hochschule (RWTH), Pauwelsstrasse 30, D-52057 Aachen, Germany;
thorstenreffelmann{at}web.de
Citation
Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease
Publication history
- Accepted August 22, 2001
- First published January 1, 2002.
Online issue publication
March 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Heart